Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Star
1761.3000 -14.80 (-0.83%)
NSE Aug 25, 2026 10:16 AM
Volume: 109.3K
 

1761.30
-0.83%

Outperformance across metrics; stellar start to the post-IPO phase

Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
Rubicon Research has gained 85.45% in the last 3 Months
More from Rubicon Research Ltd.
Recommended